These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62 related articles for article (PubMed ID: 6429185)
1. Insulin-degrading activity in mononuclear and polymorphonuclear circulating leukocytes of nondiabetic and diabetic subjects. Theiss WC; Rupp GM; Varandani PT J Clin Endocrinol Metab; 1984 Aug; 59(2):344-9. PubMed ID: 6429185 [TBL] [Abstract][Full Text] [Related]
2. Insulin degradation: radioimmunoassay for glutathione-insulin transhydrogenase and its application. Varandani PT; Nafz MA Diabetologia; 1985 Jun; 28(6):379-84. PubMed ID: 3930332 [TBL] [Abstract][Full Text] [Related]
3. Localization of glutathione-insulin transhydrogenase (protein-disulfide interchange enzyme) in pancreas using immunocytochemistry, immunodiffusion, and enzymatic activity assay techniques. Taylor CA; Varandani PT Eur J Cell Biol; 1985 Nov; 39(1):97-104. PubMed ID: 3936713 [TBL] [Abstract][Full Text] [Related]
4. Mononuclear and polymorphonuclear leukocytes show increased fructose-1,6-bisphosphatase activity in patients with type 1 diabetes mellitus. Sybirna N; Dziewulska-Szwajkowska D; Barska M; Dzugaj A Cell Biol Int; 2006 Jul; 30(7):624-30. PubMed ID: 16725352 [TBL] [Abstract][Full Text] [Related]
5. The occurrence of glutathione-insulin transhydrogenase in the retina. Varandani PT; Organisciak DT; Nafz MA Invest Ophthalmol Vis Sci; 1982 Jun; 22(6):715-9. PubMed ID: 6804408 [TBL] [Abstract][Full Text] [Related]
6. Insulin degradation. XVIII. On the regulation of glutathione-insulin transhydrogenase in the hyperglycemic obese (ob/ob) mouse. Varandani PT; Nafz MA Biochim Biophys Acta; 1976 Dec; 451(2):382-92. PubMed ID: 187226 [TBL] [Abstract][Full Text] [Related]
7. Insulin-degrading neutral cysteine proteinase activity of adipose tissue and liver of nondiabetic, streptozotocin-diabetic, and insulin-treated diabetic rats. Hern EP; Shroyer LA; Varandani PT Arch Biochem Biophys; 1987 Apr; 254(1):35-42. PubMed ID: 3555342 [TBL] [Abstract][Full Text] [Related]
8. The thiol-proteindisulfide-oxidoreductase--a new marker enzyme of monocytes from peripheral blood. Götze D; Held C; Klemm K; Mansfeld HW; Schön E; Ansorge S Allerg Immunol (Leipz); 1986; 32(4):227-31. PubMed ID: 2951987 [TBL] [Abstract][Full Text] [Related]
9. The insulin and glucagon degrading proteinase of rat liver. Separation of the proteinase from the thiol-proteindisulfide oxidoreductases. Ansorge S; Bohley P; Kirschke H; Langner J; Wiederanders B Biomed Biochim Acta; 1984; 43(1):29-38. PubMed ID: 6372796 [TBL] [Abstract][Full Text] [Related]
10. Increased levels of methylglyoxal-metabolizing enzymes in mononuclear and polymorphonuclear cells from insulin-dependent diabetic patients with diabetic complications: aldose reductase, glyoxalase I, and glyoxalase II--a clinical research center study. Ratliff DM; Vander Jagt DJ; Eaton RP; Vander Jagt DL J Clin Endocrinol Metab; 1996 Feb; 81(2):488-92. PubMed ID: 8636255 [TBL] [Abstract][Full Text] [Related]
11. The occurrence of glutathione-insulin transhydrogenase (protein-disulfide interchange enzyme) in the lens. Darrow RM; Morris JI; Organisciak DT; Varandani PT Curr Eye Res; 1988 Sep; 7(9):861-9. PubMed ID: 3180835 [TBL] [Abstract][Full Text] [Related]
12. The immunochemical identification of a thiol-protein disulfide oxidoreductase (glutathione-insulin transhydrogenase) in pancreatic islets. Kohnert KD; Ansorge S; Zühlke H Mol Cell Endocrinol; 1981 Jun; 22(3):305-13. PubMed ID: 6788621 [TBL] [Abstract][Full Text] [Related]
13. Production and characterization of a monoclonal antibody to rat liver thiol: protein-disulfide oxidoreductase/glutathione-insulin transhydrogenase. Roth RA; Mesirow ML Biochim Biophys Acta; 1984 Jul; 788(2):189-92. PubMed ID: 6743666 [TBL] [Abstract][Full Text] [Related]
14. Nonlatent and latent hepatic glutathione-insulin transhydrogenase activity during perinatal development and liver regeneration in rats and in rat placenta. Hern EP; Varandani PT Biochem Biophys Res Commun; 1983 Nov; 116(3):909-15. PubMed ID: 6418174 [TBL] [Abstract][Full Text] [Related]
15. Effect of insulin and glucose on the activity of insulin-degrading enzymes in rat liver. Jurcovicová J; Németh S; Vigas M Endocrinol Exp; 1977 Sep; 11(3):209-13. PubMed ID: 303991 [TBL] [Abstract][Full Text] [Related]
16. Chitotriosidase activity in plasma and mononuclear and polymorphonuclear leukocyte populations. Bouzas L; Carlos Guinarte J; Carlos Tutor J J Clin Lab Anal; 2003; 17(6):271-5. PubMed ID: 14614752 [TBL] [Abstract][Full Text] [Related]
17. Characterization of an insulin degrading enzyme from cultured human lymphocytes. Roth RA; Mesirow ML; Cassell DJ; Yokono K; Baba S Diabetes Res Clin Pract; 1985 Mar; 1(1):31-9. PubMed ID: 3915257 [TBL] [Abstract][Full Text] [Related]
18. Distribution of thiol-protein disulfide oxidoreductase, insulin-glucagon proteinase and cathepsin D in different cell types of the rat liver. Ansorge S; Wiederanders B; Riemann S; Brouwer A; Knook DL Biomed Biochim Acta; 1984; 43(11):1213-21. PubMed ID: 6442577 [TBL] [Abstract][Full Text] [Related]
19. Production of a monoclonal antibody directed against rat liver glutathione-insulin transhydrogenase. Dawson DB; Smith RA; Varandani PT Biochem Biophys Res Commun; 1984 Dec; 125(2):668-74. PubMed ID: 6517917 [TBL] [Abstract][Full Text] [Related]
20. Mononuclear leukocytes from obese patients with type II diabetes have reduced activity of hexokinase, 6-phosphofructokinase and glucose-6-phosphate dehydrogenase. Muggeo M; Moghetti P; Querena M; Cacciatori V; Zoppini G; Zenere M; Tosi F; Travia D; Bonora E Horm Metab Res; 1993 Mar; 25(3):160-4. PubMed ID: 8477954 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]